EA201590078A1 - Вакцина против пневмонии, вызываемой streptococcus pneumoniae, на основе гибридного белка - Google Patents
Вакцина против пневмонии, вызываемой streptococcus pneumoniae, на основе гибридного белкаInfo
- Publication number
- EA201590078A1 EA201590078A1 EA201590078A EA201590078A EA201590078A1 EA 201590078 A1 EA201590078 A1 EA 201590078A1 EA 201590078 A EA201590078 A EA 201590078A EA 201590078 A EA201590078 A EA 201590078A EA 201590078 A1 EA201590078 A1 EA 201590078A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- streptococcus pneumoniae
- pneumoniae
- hybrid protein
- vaccine against
- vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Проблема, которая должна быть решена: отсутствие безопасной эффективной вакцины для профилактики и лечения обусловленных Streptococcus pneumoniae (S.pneumoniae) заболеваний, способной обеспечивать защиту против всех штаммов S.pneumoniae (отсутствие универсальной вакцины против пневмококков). Решение: вакцина на основе гибридного белка, состоящего из иммуногенных эпитопов консервативных белков Streptococcus pneumoniae: PspA, Spr1895 и PsaA, а также компонентов флагеллина (FliC1, FliC2), функционирующих в качестве безопасного адъюванта, и соответственно гомологичных им белков или пептидов, не менее чем на 60% по аминокислотной последовательности соединенных гибкими мостиками. Продемонстрированы безопасность, эффективность и как профилактический, так и терапевтический эффекты.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012126328/15A RU2510281C2 (ru) | 2012-06-22 | 2012-06-22 | ВАКЦИНА ПРОТИВ ПНЕВМОНИИ, ВЫЗЫВАЕМОЙ Streptococcus pneumoniae, НА ОСНОВЕ ГИБРИДНОГО БЕЛКА |
PCT/RU2013/000525 WO2013191591A1 (en) | 2012-06-22 | 2013-06-21 | Chimeric protein vaccine against pneumonia caused by streptococcus pneumoniae |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201590078A1 true EA201590078A1 (ru) | 2015-06-30 |
EA027981B1 EA027981B1 (ru) | 2017-09-29 |
Family
ID=49769080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201590078A EA027981B1 (ru) | 2012-06-22 | 2013-06-21 | Вакцина против пневмонии, вызываемой streptococcus pneumoniae, на основе гибридного белка |
Country Status (13)
Country | Link |
---|---|
US (1) | US9345757B2 (ru) |
EP (1) | EP2863944B1 (ru) |
JP (1) | JP6195089B2 (ru) |
KR (1) | KR20150034192A (ru) |
CN (1) | CN104470538B (ru) |
BR (1) | BR112014032135A2 (ru) |
CU (1) | CU24238B1 (ru) |
EA (1) | EA027981B1 (ru) |
HK (1) | HK1208632A1 (ru) |
MX (1) | MX355642B (ru) |
RU (1) | RU2510281C2 (ru) |
UA (1) | UA116634C2 (ru) |
WO (1) | WO2013191591A1 (ru) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104844712B (zh) * | 2015-04-03 | 2019-06-28 | 长春百克生物科技股份公司 | 肺炎链球菌蛋白抗原及其制备方法和应用 |
RU2591809C1 (ru) * | 2015-07-21 | 2016-07-20 | Андрей Дмитриевич Протасов | Способ активации факторов противовирусной защиты у пациентов с хронической обструктивной болезнью легких |
RU2627602C2 (ru) * | 2015-12-29 | 2017-08-09 | Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) | Способ получения химерного рекомбинантного белка fliC:pagN |
CA3044112A1 (en) | 2016-12-03 | 2018-06-07 | The Uab Research Foundation | Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein a |
EP3661546B1 (en) * | 2017-08-03 | 2023-12-13 | Intervet International B.V. | A vaccine for protection against streptococcus suis |
RU2687488C1 (ru) * | 2018-07-12 | 2019-05-14 | Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский и технологический институт биологической промышленности" ФГБНУ ВНИТИБП | Формолвакцина полиштаммная против пневмоний телят стрептококковой этиологии |
RU2720614C9 (ru) * | 2020-04-23 | 2021-02-09 | федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации | Иммунобиологическое средство и способ его использования для индукции специфического иммунитета против вируса тяжелого острого респираторного синдрома SARS-CoV-2 (варианты) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6936252B2 (en) | 1998-07-27 | 2005-08-30 | Microbial Technics Limited | Streptococcus pneumoniae proteins and nucleic acid molecules |
CA2379327A1 (en) * | 1999-06-10 | 2000-12-21 | Uab Research Foundation | Pneumococcal surface protein combination vaccine |
GB0022742D0 (en) * | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
WO2002083855A2 (en) | 2001-04-16 | 2002-10-24 | Wyeth Holdings Corporation | Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
EP2314719A1 (en) | 2003-04-15 | 2011-04-27 | Intercell AG | S. pneumoniae antigens |
EP1477802A1 (en) | 2003-05-16 | 2004-11-17 | Erasmus Universiteit Rotterdam | Method for selecting and producing vaccine components and vaccines based thereon |
EP2371843B1 (en) | 2005-05-19 | 2014-09-17 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services | Functional epitopes of streptococcus pneumoniae psaA antigen and uses thereof |
AR058707A1 (es) * | 2005-12-22 | 2008-02-20 | Glaxosmithkline Biolog Sa | Vacuna, procedimiento para fabricarla y su uso |
SI2300609T1 (sl) * | 2008-06-25 | 2014-04-30 | Inserm Institut National De La Sante Et De La Recherche Medicale | Nove imunoadjuvantne spojine na osnovi flagelina in njihova uporaba |
WO2010045620A1 (en) * | 2008-10-17 | 2010-04-22 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae |
US8003112B2 (en) | 2009-04-16 | 2011-08-23 | Howard University | Meningococcal and pneumococcal conjugate vaccine and method of using same |
US20120135037A1 (en) * | 2009-06-01 | 2012-05-31 | Mizel Steven B | Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same |
-
2012
- 2012-06-22 RU RU2012126328/15A patent/RU2510281C2/ru not_active IP Right Cessation
-
2013
- 2013-06-21 KR KR20157001672A patent/KR20150034192A/ko active IP Right Grant
- 2013-06-21 EA EA201590078A patent/EA027981B1/ru not_active IP Right Cessation
- 2013-06-21 UA UAA201500499A patent/UA116634C2/uk unknown
- 2013-06-21 CN CN201380037745.9A patent/CN104470538B/zh not_active Expired - Fee Related
- 2013-06-21 BR BR112014032135A patent/BR112014032135A2/pt not_active IP Right Cessation
- 2013-06-21 WO PCT/RU2013/000525 patent/WO2013191591A1/en active Application Filing
- 2013-06-21 EP EP13806364.9A patent/EP2863944B1/en active Active
- 2013-06-21 CU CUP2014000145A patent/CU24238B1/es unknown
- 2013-06-21 JP JP2015518363A patent/JP6195089B2/ja not_active Expired - Fee Related
- 2013-06-21 MX MX2014016049A patent/MX355642B/es active IP Right Grant
-
2014
- 2014-12-22 US US14/579,279 patent/US9345757B2/en active Active
-
2015
- 2015-09-25 HK HK15109455.2A patent/HK1208632A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2013191591A9 (en) | 2014-02-13 |
JP2015521618A (ja) | 2015-07-30 |
JP6195089B2 (ja) | 2017-09-20 |
MX355642B (es) | 2018-04-25 |
HK1208632A1 (en) | 2016-03-11 |
EP2863944A4 (en) | 2016-05-11 |
US20150174230A1 (en) | 2015-06-25 |
BR112014032135A2 (pt) | 2017-08-01 |
RU2012126328A (ru) | 2013-12-27 |
EP2863944A1 (en) | 2015-04-29 |
WO2013191591A1 (en) | 2013-12-27 |
EP2863944B1 (en) | 2018-12-19 |
EA027981B1 (ru) | 2017-09-29 |
WO2013191591A4 (en) | 2014-04-03 |
CN104470538B (zh) | 2017-12-22 |
KR20150034192A (ko) | 2015-04-02 |
MX2014016049A (es) | 2015-07-06 |
US9345757B2 (en) | 2016-05-24 |
CU20140145A7 (es) | 2015-04-29 |
CN104470538A (zh) | 2015-03-25 |
RU2510281C2 (ru) | 2014-03-27 |
UA116634C2 (uk) | 2018-04-25 |
CU24238B1 (es) | 2017-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201590078A1 (ru) | Вакцина против пневмонии, вызываемой streptococcus pneumoniae, на основе гибридного белка | |
NZ708144A (en) | Recombinant adenoviruses and use thereof | |
EP4104854A3 (en) | Multivalent vaccines for rabies virus and coronaviruses | |
WO2015095811A8 (en) | Combination therapy with neoantigen vaccine | |
MX364689B (es) | Vacuna peptidica para prevencion e inmunoterapia de la demencia tipo alzheimer. | |
EA201391240A1 (ru) | Слитые белки и комбинированные вакцины, содержащие белок е и пилин а haemophilus influenza | |
EA201491754A1 (ru) | Вакцина против rsv | |
NZ602278A (en) | Bluetongue virus recombinant vaccines and uses thereof | |
NZ703597A (en) | Mutant fragments of ospa and methods and uses relating thereto | |
EA201290675A1 (ru) | Вакцинные векторы и способы усиления иммунных ответов | |
NZ602693A (en) | Immunogenic proteins and compositions for the treatment and prevention of streptococcus agalactiae | |
IN2015MN00038A (ru) | ||
EA201690115A1 (ru) | Комбинированные иммуногенные композиции | |
MX363149B (es) | Vacunas de nucleoproteina de la influenza. | |
PH12015502844A1 (en) | Mammalian milk osteopontin for enhancing immune responsiveness | |
NZ704188A (en) | Attenuated swine influenza vaccines and methods of making and use thereof | |
WO2013171661A3 (en) | Adjuvant formulations and methods | |
GB2515222A (en) | Use of flagellin as a vaccine | |
EA201500770A1 (ru) | Поливалентная вакцина против гриппа на основе гибридного белка | |
MX2013005646A (es) | Composiciones de vacuna de fragmentos de clivaje de la inmunoglobulina. | |
EA201600347A3 (ru) | Гибридный белок, днк, генетическая конструкция, продуцент, вакцина на основе гибридного белка для профилактики и лечения туберкулеза (варианты) | |
EA201501001A1 (ru) | Вакцина для профилактики и лечения ротавирусной инфекции, содержащая гибридный белок в качестве активного агента (варианты) | |
WO2015070207A3 (en) | Ama-1 epitopes, antibodies, compositions, and methods of making and using the same | |
WO2015048785A3 (en) | Mosaic conserved region hiv immunogenic polypeptides | |
WO2012027473A3 (en) | Immunogenic compositions comprising alphavirus vectored dengue virus e protein antigens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ KG TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): BY KZ RU |